In a similar clinical context, in adult polyglucosan body disease (APBD), due to variants in the GBE1 gene, neuropathy, dysautonomia, parkinsonism, cognitive decline, and leukoencephalopathy can be observed in varying degrees in affected adult individuals [25]. Here, GBE1 is linked to dysautonomia.